Acquisitions - Narratives (Details) $ in Thousands, € in Millions				3 Months Ended						9 Months Ended		12 Months Ended
	Jan. 14, 2022 USD ($)	Dec. 09, 2021 USD ($) installment	Nov. 22, 2021 USD ($)	Sep. 30, 2022 USD ($)	Jun. 30, 2022 USD ($)	Mar. 31, 2022 USD ($)	Sep. 30, 2021 USD ($)	Jun. 30, 2021 USD ($)	Mar. 31, 2021 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($)	Dec. 09, 2021 EUR (€)
Adjustment to goodwill										$ (6,496)
Change in fair value							$ 8,530			(2,605)	$ 8,760
Net loss				$ (170,758)	$ (173,296)	$ (156,489)	(106,671)	$ (99,634)	$ (60,746)	(500,543)	(267,051)
Joule Processing LLC
Earn-out payments	$ 130,000			41,700						41,700
Achievement of revenue targets	90,000
Achievement of cost targets	40,000
Adjustment to goodwill				0						100
Acquired	60,522
Fair value of contingent consideration				36,900						36,900
Change in fair value				0						4,800
Revenue				600						3,900
Joule Processing LLC | Developed Technology Rights
Acquired	$ 59,200
Estimated useful lives of acquired finite-lived intangible assets	15 years
Joule Processing LLC | Trade Names
Acquired	$ 800
Estimated useful lives of acquired finite-lived intangible assets	4 years
Joule Processing LLC | Noncompete Agreements
Acquired	$ 500
Estimated useful lives of acquired finite-lived intangible assets	6 years
Applied Cryo Technologies
Percentage of outstanding shares			100.00%
Earn-out payments			$ 30,000	14,000						14,000
Achievement of revenue targets			15,000
Achievement of cost targets			15,000
Adjustment to goodwill				0						500
Acquired			70,484
Fair value of contingent consideration				13,700						13,700
Change in fair value				0						(300)
Deferred tax liability			16,541									$ 16,500
Reduction to valuation allowance												16,500
Deferred tax benefit												$ 16,500
Revenue				11,700						44,700
Applied Cryo Technologies | Developed Technology Rights
Acquired			$ 26,300
Estimated useful lives of acquired finite-lived intangible assets			15 years
Applied Cryo Technologies | Customer Relationships
Acquired			$ 26,600
Estimated useful lives of acquired finite-lived intangible assets			15 years
Applied Cryo Technologies | Trade Names
Acquired			$ 13,700
Estimated useful lives of acquired finite-lived intangible assets			15 years
Applied Cryo Technologies | Noncompete Agreements
Acquired			$ 1,000
Estimated useful lives of acquired finite-lived intangible assets			3 years
Applied Cryo Technologies | Customer Backlog
Acquired			$ 2,900
Estimated useful lives of acquired finite-lived intangible assets			1 year
Frames Holding B.V.
Percentage of outstanding shares		100.00%											100.00%
Earn-out payments | €													€ 30.0
Achievement of cost targets				29,100						29,100
Acquired		$ 50,478
Contingent consideration, number of installments | installment		2
Increase in goodwill				0						7,200
Fair value of contingent consideration				26,200						26,200
Change in fair value				0						1,100
Deferred tax liability		$ 11,259		4,100						4,100
Revenue				$ 25,400						$ 76,000
Frames Holding B.V. | Pro Forma
Revenue							159,304				387,623
Net loss							$ (105,294)				$ (264,640)
Frames Holding B.V. | Developed Technology Rights
Estimated useful lives of acquired finite-lived intangible assets		8 years
Fair value of acquisition		$ 5,300
Frames Holding B.V. | Customer Relationships
Fair value of acquisition		$ 27,200
Frames Holding B.V. | Customer Relationships | MPEEM approach
Estimated useful lives of acquired finite-lived intangible assets		17 years
Frames Holding B.V. | Trade Names
Estimated useful lives of acquired finite-lived intangible assets		8 years
Fair value of acquisition		$ 11,600
Frames Holding B.V. | Noncompete Agreements
Estimated useful lives of acquired finite-lived intangible assets		4 years
Fair value of acquisition		$ 4,900
Frames Holding B.V. | Backlog
Estimated useful lives of acquired finite-lived intangible assets		1 year
Fair value of acquisition		$ 1,400